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The mTORC1 complex is central to the cellular res-
ponse to changes in nutrient availability. The sig-
naling adaptor p62 contributes tomTORC1activation
in response to amino acids and interacts with TRAF6,
which is required for the translocation of mTORC1
to the lysosome and the subsequent K63 poly-
ubiquitination and activation of mTOR. However,
the signal initiating these p62-driven processes was
previously unknown. Here, we show that p62 is phos-
phorylated via a cascade that includes MEK3/6 and
p38d and is driven by the PB1-containing kinase
MEKK3. This phosphorylation results in the recruit-
ment of TRAF6 to p62, the ubiquitination and activa-
tion of mTOR, and the regulation of autophagy and
cell proliferation. Genetic inactivation of MEKK3 or
p38d mimics that of p62 in that it leads to inhibited
growth of PTEN-deficient prostate organoids. Anal-
ysis of humanprostate cancer samples showedupre-
gulation of these three components of the pathway,
which correlated with enhanced mTORC1 activation.
INTRODUCTION
Cell metabolism is responsive to the availability of environmental
and intracellular nutrients. The mTORC1 kinase complex is a
key nutrient sensor and an essential mediator of this response
via its actions as a regulator of anabolism and autophagy (Hay
and Sonenberg, 2004; Laplante and Sabatini, 2012). The aber-
rant activation of mTORC1 has important repercussions in
several diseases, including cancer (Guertin and Sabatini, 2007;
Laplante and Sabatini, 2012; Sabatini, 2006). An essential step
in amino-acid-induced activation of mTORC1 is its translocation
to the lysosome, mediated by the Rag guanosine triphospha-
tases (GTPases), where it is activated by another GTPase termed
Rheb (Dura´n and Hall, 2012; Sancak et al., 2008, 2010; Yuan
et al., 2013). A lysosomal pentameric complex termed ragulator,
along with the vacuolar-ATPase, have been proposed to pro-
mote the exchange of GDP for GTP on RagA or RagB inCellamino-acid-activated cells (Sancak et al., 2010). Additionally,
the Rags have been shown to be regulated by other proteins
including the GATOR1 complex (Bar-Peled et al., 2013), FLCN
(Petit et al., 2013; Tsun et al., 2013), and sestrins (Budanov
and Karin, 2008; Chantranupong et al., 2014). There is also evi-
dence for Rag-independent mechanisms of mTORC1 activation.
For example, it has recently been reported that Rab1A mediates
mTORC1 activity in a Rag-independent manner through the for-
mation of a Rheb-mTORC1 complex in the Golgi (Thomas et al.,
2014). Moreover, RagA-null cells display a diffuse cytosolic
localization of mTOR and RagC but can, nonetheless, maintain
the activity of mTORC1 (Efeyan et al., 2014). Also, it has recently
been shown that RheB-null cells retain significant levels of
mTORC1 activity (Groenewoud et al., 2013). Moreover, very
recent results suggest that the mechanism whereby glutamine
activates mTORC1 differs from that of leucine as it is indepen-
dent of the Rag-Ragulator cascade and is mediated by Arf-1
(Jewell et al., 2015). Therefore, it is clear that our comprehension
of mTORC1 activation is still fragmentary and that more work is
necessary to achieve a thorough understanding of the mecha-
nisms that modulate its activity in response to nutrients.
The signaling adaptor p62 (also known as SQSTM1) is cen-
tral to cell survival and proliferation through the activation of
mTORC1 (Duran et al., 2008, 2011; Linares et al., 2013; Moscat
and Diaz-Meco, 2009, 2011; Valencia et al., 2014). This is
achieved through the interaction of p62 with raptor, a distinc-
tive component of the mTORC1 complex, and by facilitating
mTORC1 translocation to the lysosome, a process that likely in-
volves the interaction of p62 with the Rag proteins (Duran et al.,
2011). Our recent data demonstrate that the E3-ubiquitin ligase
TRAF6 is another important player in this process (Linares
et al., 2013). That is, the interaction of TRAF6 with p62 facilitates
the lysosomal recruitment of mTORC1 and catalyzes the K63
polyubiquitination of the mTOR subunit of the complex, which
is required for its optimal activation by amino acids (Linares
et al., 2013). Therefore, the p62/TRAF6 tandem must be con-
sidered an important modulator of nutrient sensing through
mTORC1. Consistent with this notion, the loss of TRAF6, like
that of p62, attenuated proliferation and the transforming proper-
ties of cancer cells and led to enhanced autophagy, which could
be rescued by the expression of a permanently active RagB
mutant, indicating that p62 acts upstream of the Rag proteinsReports 12, 1339–1352, August 25, 2015 ª2015 The Authors 1339
Figure 1. p62 Phosphorylation at T269/S272 Was Required for mTORC1 Activation in Response to Amino Acids
(A) p62 domain organization and phosphorylation sites identified by mass spec. Phosphorylation of T269 and S272 was induced by amino acids (upper panel).
Alignment of the amino acid sequence of human p62 (264–276) with orthologs in other species is shown (lower panel).
(B) p62 phosphorylation at T269 and S272 is induced by amino acids. HEK293T cells were starved of amino acids for 50min and restimulated with amino acids for
the indicated durations. Cell lysates were analyzed by immunoblotting.
(legend continued on next page)
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(Linares et al., 2013). Thus, p62 acts as a scaffold, bringing com-
ponents involved in the control of mTORC1 signaling to the cor-
rect cellular location (Duran et al., 2011). How mTORC1 is linked
to the upstream nutrient-sensing machinery and the potential
role of p62 in that process are key unresolved issues.
Here, we demonstrate that p62 phosphorylation at T269/S272
is a critical event in channeling the amino acid response to
mTORC1 activation, likely due to its ability to orchestrate the
binding of p62 with the different components of the mTORC1-
signaling complex. That is, we found that p62 organizes amolec-
ular platform with a kinase cascade that is initiated by MEKK3
and triggers the activation of p38d, is driven by PB1-domain in-
teractions between p62 and MEKK3, and is located on the lyso-
somal surface. These kinases, like p62, are selectively required
for amino-acid-induced mTORC1 activation whereas dispens-
able for insulin signaling and are required for effective control
of cell growth, autophagy, and transformation. These findings
define a critical mechanism to transmit nutrient-sensing signals
to the mTORC1 complex, which is mediated by phosphorylation
of the scaffold protein p62.
RESULTS
p62 Phosphorylation Is Required for the Activation of
mTORC1 by Amino Acids
The mechanisms whereby mTORC1 respond to amino acids are
not fully understood. Our previous data demonstrated that p62 is
a scaffold in this pathway (Duran et al., 2011; Linares et al., 2013),
but the process by which it senses amino acids remains to be
elucidated. Recent studies have suggested phosphorylation as
a regulatory mechanism for the control of p62 function (Ichimura
et al., 2013; Linares et al., 2011; Matsumoto et al., 2011). There-
fore, we hypothesized that nutrient-driven p62 phosphorylation
might underlie p62-mediated activation of mTORC1 in response
to amino acids. To address this possibility, we generated
HEK293T cells stably expressing FLAG-tagged p62 or FLAG
control. Cells were stimulated with amino acids, after which
anti-FLAG immunoprecipitates were subjected to liquid chroma-
tography coupled to mass spectrometry (LC-MS). We found that
p62 exhibited low-abundance baseline phosphorylation at resi-
dues S28, T221, and S224 that was constitutive and not changed
upon amino acid stimulation (Figure 1A, upper panel). In con-
trast, we found that phosphorylation at residues T269 and(C) p62 phosphorylation was determined in response to different amino acids. H
amino acids for 30 min.
(D) Amino acid starvation inhibits p62 phosphorylation and mTORC1 activation. H
lysates were analyzed by immunoblotting.
(E) Mutation of p62-T269/S272 sites to alanine (p62T269/S272AA) abolished p62 p
FLAG-p62WT or FLAG-p62T269/S272AA were treated and analyzed as in (B).
(F) The p62T269/S272AA mutant was not able to reconstitute mTOR activation in p6
were treated as in (B). Cell lysates were analyzed by western blot.
(G) RagBGTP overexpression rescued the defects in mTOR activation by amino ac
expressing FLAG-p62WT, FLAG-p62T269/S272AA, or FLAG-p62T269/S272AA and FLAG
(H) p62 phosphorylation was not required for mTOR activation by insulin. HEK293T
serum for 24 hr and stimulated with insulin for the indicated durations. Cell lysat
(I) The p62T269/S272AAmutant eliminated the interaction of p62with different compo
or FLAG-p62T269/S272AA were treated as in (B). Cell lysates and FLAG-tagged imm
Results are representative of three experiments. See also Figure S1.
CellS272 was markedly induced by amino acids (Figure 1A, upper
panel). These sites, and their surrounding sequences, were
highly conserved across species (Figure 1A, lower panel). To
establish the relevance of these phosphorylation events in
mTORC1 signaling, we used a phosphospecific antibody gener-
ated against the human p62 peptide SRLT(P)PVS(P)PES(C),
which allowed us to detect phospho-T269/S272. Interestingly,
immunoblot analysis revealed the strong phosphorylation of
p62 at T269/S272 upon re-addition of all amino acids to cells
amino acid starved (Figure 1B). Leucine and arginine, two key
amino acids for mTORC1 stimulation, also promoted p62-
T269/S272 phosphorylation, which correlated with the magni-
tude of mTORC1 activation, as measured by phosphorylation
of S6K (Figure 1C). Conversely, amino acid starvation resulted
in a pronounced inhibition of p62-T269/S272 phosphorylation,
concomitant with the decrease of mTORC1 activity (Figure 1D).
Mutation of p62-T269/S272 sites to alanine (p62T269/S272AA)
abolished amino-acid-induced p62 phosphorylation, demon-
strating that these are bona fide nutrient-sensitive p62 phos-
phorylation residues (Figure 1E). To explore whether phosphor-
ylation of p62 has any impact on its ability to regulate mTORC1
activity, we used p62 KO MEFs reconstituted with either p62WT
or p62T269/S272AA. Consistent with our previously published
data, mTORC1 activation in response to amino acids was
impaired in p62-deficient cells (Figure 1F) (Duran et al., 2011).
Importantly, whereas re-expression of p62WT restored mTORC1
activity in the KO MEFs, that of p62T269/S272AA failed to
do so, as demonstrated by phosphorylation of multiple mTORC1
downstream targets including S6K, S6, and 4EBP1 (Fig-
ure 1F). Furthermore, overexpression of an active RagB-GTP-
bound mutant rescued the mTORC1 inhibition caused by
p62T269/S272AA expression (Figure 1G). This is in agreement
with p62 acting upstream of the Rag GTPases in the control of
mTORC1 signaling in the amino acid pathway and supports
the notion that p62 phosphorylation also lies upstream of Rag
activation (Duran et al., 2011). In keeping with a specific role
for p62 in the amino acid, but not in the insulin pathway, insulin
did not promote p62 phosphorylation, which, in turn, was
not required for insulin-induced mTORC1 activity (Figure 1H).
Notably, p62 phosphorylation was also critical for assembly of
the amino-acid-induced p62-mTORC1 complex, as demon-
strated by the ability of p62T269/S272AA expression to inhibit the
interaction of p62 with the different components of mTORC1,EK293T cells were starved of amino acids and restimulated with the indicated
EK293T cells were starved of amino acids for the indicated durations. Total cell
hosphorylation in response to amino acids. HEK293T cells stably expressing
2KO MEFs. WT and p62KO MEFs, reconstituted with p62WT or p62T269/S272AA,
ids in cells stably expressing the p62T269/S272AA mutant. HEK293T cells stably
-RagBGTP were treated as in (B) and immunoblotted for the specified proteins.
cells stably expressing FLAG-p62WT or FLAG-p62T269/S272AA were deprived of
es were analyzed by western blot.
nents of themTORC1 complex. HEK293T cells stably expressing FLAG-p62WT
unoprecipitates were immunoblotted to detect the indicated proteins.
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Figure 2. MEKK3 Was a Critical Kinase for p62 Phosphorylation and mTORC1 Activation in Response to Amino Acids
(A) Schematic of the different types of PB1 domains based on the presence of an acid cluster (type I), basic cluster (type II), or both in the same domain (type I/II).
(B) p62 and MEKK3 domain architecture and schematic of the interaction between the acidic cluster of the PB1 domain of p62 and the basic domain of MEKK3.
(legend continued on next page)
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including mTOR, raptor, and TRAF6 (Figure 1I). Mutation of
p62-T269/S272 sites to aspartic acid did not mimic p62 phos-
phorylation and did not restore mTORC1 activation or TRAF6
recruitment (Figures S1A and S1B). Together, these findings
demonstrate that p62 phosphorylation is a key event in mTORC1
activation, selectively in response to amino acids.
MEKK3 Is a Critical Kinase for Amino-Acid-Induced p62
Phosphorylation
An important question arising from these results is the identity of
the amino-acid-activated p62 kinase. In this regard, the structure
of p62 includes a PB1 domain, which is a protein-protein interac-
tion module that is present in kinases, such as the atypical PKCs
(PKCz and PKCl/i) and MEKK3, as well as in signaling adapters
such as Par-6 and NBR1 (Moscat et al., 2006; Sanchez et al.,
1998). Protein dimerization occurs by PB1-PB1 interactions
through a b-grasp topology in a front-to-back orientation of the
two PB1 domains. This involves electrostatic interactions of a
cluster of basic residues in one of the PB1 domains that can
bind clusters of acidic amino acids in the back of a second PB1
(Figure 2A) (Moscat et al., 2006; Sumimoto et al., 2007). The
PB1 domains can be classified into three different types based
on the presence of the acid cluster (type I), the basic cluster
(type II), or both in the same domain (type I/II; Figure 2A). The
PB1 domain of p62 belongs to the type I/II group and, therefore,
canaccommodate interactions throughboth faces (Moscat et al.,
2006; Sumimoto et al., 2007). In this regard, we previously
showed that proteins such as PKCz, PKCl/i, or NBR1, which
interact with p62 through its basic cluster, were not required for
the activation of mTORC1 (Duran et al., 2011). In contrast, we
found that disruption of the acidic cluster of p62, by mutation of
D69/D73 to alanine, abolished p62 phosphorylation in response
to amino acids (Figures 2B and 2C). This suggests that, if a
PB1-domain protein is involved in mTORC1 activation, it must
interact with the acidic cluster of p62 using its basic cluster. Inter-
estingly, the PB1-domain-containing kinase, MEKK3, harbors a
type II PB1 domain and previous results have shown that the
p62 D69A/D73A PB1-domain mutant is unable to interact with(C) Mutation of p62-D69/73 sites to alanine (p62D69/73AA) abolished p62 phosphor
amino acids for 50 min and restimulated with amino acids for the indicated dura
(D) MEKK3 promoted p62 phosphorylation at T269/S272. HEK293T cells were tran
blot.
(E) MEKK3-induced p62 phosphorylation required the PB1 domain of p62. HEK2
immunoblotted to detect the specified proteins.
(F) Overexpression of MEKK3, but not that of MEKK3 kinase-dead mutant, induce
transfected with the indicated plasmids were deprived of amino acids for 50min a
(G) MEKK3 expression rescued p62 phosphorylation and mTOR activation in
CRISPR/CAS9 system were reconstituted with MEKK3. Cells were deprived of a
durations. Cell lysates were immunoblotted for the specified proteins.
(H) RagBGTP overexpression rescued mTOR activation by amino acids in MEKK3-
RagBGTP were treated as in (G) and immunoblotted to detect the specified prote
(I) MEKK3 was not required for mTOR activation by insulin. Control and MEKK3-
insulin for the indicated durations. Cell lysates were analyzed by western blot.
(J)MEKK3 is a component of themTORC1 complex.mTOR immunoprecipitates a
indicated proteins.
(K) MEKK3 kinase activity was activated upon amino acid stimulation. HEK293T
immunoprecipitates were used in an in vitro phosphorylation with ATPgS, with m
immunoblotting to detect the indicated proteins.
Results are representative of three experiments. See also Figure S2.
CellMEKK3 (Figure 2B) (Nakamura et al., 2010). Consistent with
this, the overexpression of MEKK3 resulted in the phosphoryla-
tion of p62WT, but not of p62T269/S272AA (Figure 2D). Furthermore,
p62 phosphorylation in response to MEKK3 overexpression was
eliminated in the p62 PB1-domain mutant (Figure 2E). MEKK3
overexpression, but not that of a kinase-dead mutant, was able
to induce the phosphorylation of p62 at T269/S272 (Figure 2F),
which correlatedwithmTORC1activation (Figure 2F), suggesting
that MEKK3 could be a bona fide regulator of p62 phosphoryla-
tion and mTORC1 activity. Next, we determined whether
MEKK3 is required for mTORC1 activation by using the clustered
regularly interspaced short palindromic repeats (CRISPR/Cas9)
system to generate MEKK3-deficient HEK293T cells. Notably,
the loss of MEKK3 severely reduced p62 phosphorylation and
mTORC1 activation in response to amino acids, which were
both rescued by the ectopic expression of MEKK3 (Figure 2G).
Similar results were obtained with two independent sgMEKK3
clones, as well as by knocking down MEKK3 with a shRNA lenti-
viral vector in HEK293T, A549, and PC3 cells (Figures S2A–S2D).
Of note, the effects of MEKK3 deficiency in mTORC1 activation
were rescued by expression of active RagB (Figure 2H). The
loss of MEKK3 did not affect insulin-activated mTORC1, consis-
tent with the specificity of p62 in the amino acid pathway (Fig-
ure 2I). In keeping with the importance of MEKK3 in this process,
we found that, upon cell stimulation by amino acids, endogenous
MEKK3was recruited to an endogenous complex containing p62
and mTOR (Figure 2J). In addition, Figure 2K demonstrates that
the kinase activity of MEKK3 was stimulated in amino-acid-
treated cells. Collectively, these results demonstrate that p62 is
phosphorylated in response to amino acids through a MEKK3-
dependent mechanism that is critical for mTORC1 activation
and is mediated by the interaction of p62 and MEKK3 through
their respective PB1 domains.
MEK3/6 and p38d Channel MEKK3-Induced
Phosphorylation of p62 by Amino Acids
Based on these results, it is possible that p62 could be targeted
directly by MEKK3. However, when bacterially expressedylation. HEK293T cells transfected with the indicated plasmids were starved of
tions. Myc-tagged immunoprecipitates were analyzed by western blot.
sfected with the indicated plasmids, and cell lysates were analyzed bywestern
93T cells were transfected with the indicated plasmids, and cell lysates were
d p62 phosphorylation andmTORC1 activation by amino acids. HEK293T cells
nd stimulated with amino acids for 15min. Cells were analyzed by western blot.
MEKK3-deficient cells. MEKK3-deficient HEK293T cells generated with the
mino acids for 50 min and then stimulated with amino acids for the indicated
deficient cells. Control and MEKK3-deficient HEK293T cells expressing FLAG-
ins.
deficient HEK293T cells were deprived of serum for 24 hr and stimulated with
nd cell lysates fromHEK293T cells, treated as in (F), were immunoblotted for the
cells transfected with the indicated plasmids were treated as in (F). HA-tagged
yelin basic protein (MyBP) as the substrate, followed by PNBM alkylation and
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Figure 3. MEKK3/MEK3/6-p38d Induced p62 Phosphorylation in Response to Amino Acids
(A) p38d was required for mTORC1 activation in response to amino acids. Results of siRNA screening of MAPKs in mTORC1 activation.
(B) p38dwas required for p62 phosphorylation at T269/S272 in response to amino acids. p38d-deficient HEK293T cells generated with theCRISPR/CAS9 system.
Cells were deprived of amino acids for 50 min and then stimulated with amino acids for 15 min. Cell lysates were immunoblotted for the indicated proteins.
(C) RagBGTP overexpression rescued amino-acid-inducedmTOR activation in p38d-deficient cells. Control and p38d-deficient HEK293T cells, expressing FLAG-
RagBGTP, were treated as in (B). Cell lysates were immunoblotted for the indicated proteins.
(D) p38dwas not required for insulin-inducedmTORC1 activation. Control and p38d-deficient HEK293T cells were deprived of serum for 24 hr and then stimulated
with insulin for the indicated durations. Cell lysates were immunoblotted to detect the indicated proteins.
(E) p38d overexpression promotes p62 phosphorylation at T269/S272. HEK293T cells were transfected with the indicated plasmids and immunoblotted for the
specified proteins.
(F) p38d kinase activity was required for p62 phosphorylation. HEK293T cells were transfected with the indicated plasmids and immunoblotted for the specified
proteins.
(G) p38d directly phosphorylated p62 at T269/S272 in vitro. An in vitro phosphorylation assay using recombinant p62 and recombinant p38d is shown.
(H) T269/S272 sites accounted for p62 phosphorylation by p38d. FLAG-tagged immunoprecipitates from HEK293T cells were phosphorylated in vitro by re-
combinant p38d with ATPgS, followed by PNBM alkylation and immunoblotting for the indicated proteins.
(I) p38d kinase activity was activated by amino acids. HEK293T cells transfected with the indicated plasmids were treated as in (B). In vitro phosphorylation was
carried out with the FLAG-tagged immunoprecipitates and MBP-p62 recombinant protein as a substrate.
(J) MEKK3 was required for p38d-induced p62 phosphorylation by amino acids. shNT or shMEKK3 HEK293T cells transfected with the indicated plasmids were
treated as in (B). In vitro phosphorylation was carried out with the FLAG-tagged immunoprecipitates, and MBP-p62 recombinant protein was used as the
substrate.
(K) MEK3/6 was required for p62 phosphorylation and mTORC1 activation in response to amino acids. HEK293T cells transfected with scramble siRNA or MEK3
and MEK6 siRNAs and FLAG-RagBGTP were treated as in (B). Cell lysates were immunoblotted for the indicated proteins.
(legend continued on next page)
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recombinant p62was incubatedwith active recombinantMEKK3
in an in vitro kinase assay, we found that MEKK3 was not able to
directly phosphorylate p62 (Figure S3A). These results strongly
suggest the existence of other kinase that acts downstream of
MEKK3 to phosphorylate p62 in response to amino acids. Our
previously published data showed that CDK1 was able to phos-
phorylate p62 at residues T269/S272 during mitosis (Linares
et al., 2011). However, a selective CDK1 inhibitor did not affect
p62 phosphorylation in response to amino acids (Figure S3B).
To identify that kinase, because MEKK3 is a MAP3K, we
reasoned that a MAP2K/MAPK cascade could act downstream
of MEKK3 to phosphorylate p62. To address this possibility, we
individually knocked down all the members of the five distinct
groups of MAPKs characterized in mammals (Figure 3A). Cells
were stimulated with amino acids, as above, and the activation
of mTORC1 was determined. Notably, only depletion of p38d
(MAPK13) severely impaired amino-acid-induced activation of
mTORC1 (Figures 3A and S3C). Importantly, knockout of p38d
by CRISPR/Cas9 severely abolished p62 phosphorylation and
mTORC1 activation in cells stimulated with amino acids, which
was rescued by the expression of active RagB (Figures 3B and
3C). Of note, p38d-deficient cells displayed normal insulin-
inducedmTORC1 activation (Figure 3D). Similar results were ob-
tained with two other independent CRISPR/Cas9-generated
p38d KO clones (Figure S3D). Furthermore, the pharmacological
inhibition of p38d severely abrogated mTORC1 activation and
p62 phosphorylation by amino acids (Figure S3E). Interestingly,
we also found that the overexpression of WT, but not of a ki-
nase-inactive p38d (T180A/Y182F) mutant, was able to induce
the phosphorylation of p62WT, but not of p62T269/S272AA (Figures
3E and 3F). Taken together, these results demonstrate that
p38d is responsible for p62 phosphorylation and mTORC1 acti-
vation by amino acids. To determine whether p62 is actually a
direct substrate of p38d, we incubated bacterially expressed re-
combinant p62 with active p38d in an in vitro kinase assay and
found that p38d directly phosphorylated p62 at T269/S272 (Fig-
ure 3G). To confirm that these residues account for p62 phos-
phorylation by p38d, purified p62WT and p62T269/S272AA were
phosphorylated in vitro with ATP-g-S and recombinant active
p38d. Figure 3H demonstrates that p62 phosphorylation by
p38d was completely abolished in the p62T269/S272AA mutant, as
compared to p62WT, indicating that p38d is a bona fide direct
p62 T269/S272 kinase that channels MEKK3 signals in amino-
acid-activated cells.
If this model is correct, then p38d should be activated by
amino acids in a MEKK3-dependent manner. To determine
whether this was the case, HEK293T cells were transfected
with FLAG-tagged p38d, after which cells were treated with
amino acids at different times as described above. Transfected
p38d was immunoprecipitated with an anti-FLAG antibody,
and its ability to phosphorylate recombinant p62 was deter-
mined in an in vitro kinase assay. Interestingly, p38d from shNT(L) MEK3 is activated in response to amino acids. HEK293T cells transfected w
noprecipitates were used in an in vitro phosphorylation, usingMyBP as substrate,
proteins.
(M) Schematic showing that MEK3/6-p38d channels MEKK3-induced phosphory
Results are representative of three experiments. See also Figure S3.
Cellcells that were stimulated with amino acids displayed higher
enzymatic activity toward recombinant p62 than p38d from un-
stimulated shNT cells (Figure 3I). The finding that amino acid
stimulation did not increase the activity of p38d in shMEKK3 cells
(Figure 3J) clearly established that p38d is a critical downstream
target of MEKK3 in the nutrient-sensing cascade that activates
mTORC1 through p62 phosphorylation. To identify the kinase
that links MEKK3 to p38d, we tested whether MEK3 and MEK6
might be the MAP2Ks upstream of p38d. Notably, the simulta-
neous depletion of MEK3 and MEK6 severely impaired amino-
acid-induced mTORC1 activation and p62 phosphorylation,
which was rescued by the expression of active RagB (Figure 3K).
Furthermore, the kinase activity of MEK3 was stimulated in
amino-acid-treated cells (Figure 3L). Collectively, these results
demonstrate that MEKK3 is the apical kinase in an amino-acid-
sensing cascade that includes MEK3/MEK6 and p38d and that
leads to p62 phosphorylation, which is a critical step for
mTORC1 activation in response to amino acids (Figure 3M).
MEKK3 and p38d Control Lysosomal Translocation
of mTOR
To be activated by amino acid stimulation, mTORC1 must un-
dergo translocation from the cytoplasm to the lysosome (Sancak
et al., 2008). Given that MEKK3 and p38d are necessary for
amino-acid-induced mTORC1 activity, we next investigated
the subcellular localization of MEKK3 and p38d by confocal
immunofluorescence microscopy in both starved and amino-
acid-stimulated cells. Double staining of endogenous MEKK3
or p38d and lysosomal-associated membrane protein 2
(LAMP2) revealed the localization of both kinases at the lyso-
some, which was independent of nutrient availability (Figures
4A and 4B). The antibodies used in this experiment were vali-
dated for immunofluorescence in MEKK3 or p38d knocked
down cells (Figure S4). Cell fractionation confirmed the constitu-
tive localization of MEKK3, p38d, and p62, along with Lamp2, in
the heavy membrane lysosomal fraction (Figure 4C). Of great
functional relevance, the knockdown of either MEKK3 or p38d
impaired the colocalization of mTORC1 with LAMP2 in response
to amino acids (Figure 4D), demonstrating that p38d andMEKK3,
like p62, are required for mTORC1 translocation to the lysosome.
Role of the MEKK3/p38d Cascade in the
Polyubiquitination of mTOR
TRAF6 is recruited to the p62-mTORC1 complex upon amino
acid stimulation, and this promoted the K63 polyubiquitination
of mTOR, a key event in amino-acid-dependent activation of
mTORC1 (Linares et al., 2013). Our current results link this pro-
cess to the MEKK3/p38d cascade, because depletion of either
kinase severely impaired the interaction of TRAF6 with p62 (Fig-
ures 5A and 5B). This suggests a critical role for the phosphory-
lation of p62 by the MEKK3/p38d cascade in the binding of
TRAF6 to p62, consistent with the fact that p62T269/S272AA didith the indicated plasmids were treated as in (B). FLAG-tagged MEK3 immu-
with ATPgS followed by PNBM alkylation and immunoblotting for the indicated
lation of p62 and mTORC1 activation by amino acids.
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Figure 4. MEKK3/p38d Cascade Is Required
for the Lysosomal Translocation of mTOR
(A and B) MEKK3 and p38d localize at the lysosome
in an amino-acid-independent manner. Images of
HeLA cells co-immunostained for MEKK3 and
LAMP2 (A) or p38d and LAMP2 (B) are shown. Cells
were starved for 50 min and then stimulated with
amino acids for 10 min before processing. In
all images, graphs show the areas of staining
overlap (merge). The scale bars represent 10 mm.
The quantification of colocalization was carried
out on at least 15 cells per condition from two in-
dependent experiments. Results are shown as
means ± SEM.
(C) MEKK3, p38d, and p62 were present in the
lysosomal fraction. HEK293T cells were treated as
in (A), and lysates were separated into heavy
membrane and light/cytosolic fractions.
(D) MEKK3 and p38d deficiency prevented amino-
acid-induced translocation of mTOR to lysosomes.
Images of control, MEKK3-deficient, or p38d-defi-
cient HEK293T cells treated and analyzed as in (A)
that were co-immunostained to detect mTOR and
LAMP2 are shown. The scale bars represent 10 mm.
Results are shown as means ± SEM. ***p < 0.001.
Images are representative of two independent
experiments. See also Figure S4.
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Figure 5. The MEKK3/p38d Cascade Was
Required for TRAF6-Catalyzed K63 Poly-
ubiquitination of mTOR in Response to
Amino Acids
(A and B) Knockdown of MEKK3 or p38d impaired
the interaction of TRAF6 with p62 in response
to amino acids. shNT, shMEKK3, or shp38d
HEK293T cells were deprived of amino acids for
50 min and then restimulated with amino acids for
30 min. Cell lysates and p62 immunoprecipitates
were analyzed by western blot for the indicated
proteins.
(C–E) MEKK3, p38d, and p62 phosphorylation
were required for polyubiquitination of mTOR
in response to amino acids. shNT, shMEKK3,
and shp38d HEK293T cells or cells stably ex-
pressing FLAG-p62WT or FLAG-p62T269/S272AA
were treated as in (A). Cell lysates and mTOR im-
munoprecipitates were immunoblotted for the
indicated proteins.
Results are representative of three experiments.not interactwith TRAF6 in amino-acid-stimulated cells (Figure 1I).
As predicted by this model, endogenous polyubiquitination of
mTOR in response to amino acids was severely inhibited by
the deficiency of either MEKK3 or p38d (Figures 5C and 5D).
Furthermore, the endogenous polyubiquitination of mTOR in
response to amino acids was inhibited in cells expressing the
p62T269/S272AA mutant compared with those expressing p62WT
(Figure 5E). Collectively, these data demonstrate that p62 phos-
phorylation by p38d is a key event in the recruitment of mTORC1
to the lysosome and in its subsequent activation by TRAF6-
mediated polyubiquitination.
The MEKK3/p38d Cascade Contributes to Cell
Proliferation and Autophagy
A well-established function of mTORC1 is to control cell size
(Fingar et al., 2002). In keeping with a critical role for MEKK3
and p38d in the activation of mTORC1, cells deficient in
MEKK3, p38d, or p62 were significantly smaller thanWT controls
(Figure 6A). On the other hand, it is known that mTORC1 activa-
tion promotes cell proliferation and transformation while inhibit-
ing autophagy (Kim et al., 2011; Yu et al., 2010). Consistent with
this, the knockdown of MEKK3 or p38d in PC3 prostate cancer
(PCa) cells significantly reduced cell proliferation under normal
growing conditions (Figures 6B and 6C), and this effect was
rescued by the expression of a constitutively active mutant of
RagB (Figures 6D and 6E). Given that nutrient starvation induces
autophagy through inhibition of mTORC1 (Kim et al., 2011; Yu
et al., 2010), we knocked down MEKK3 or p38d and determined
the effect on autophagy. Interestingly, reduction in the levels of
either of these kinases resulted in enhanced LC3 processing,
which was even more apparent when cells were incubated
with bafilomycin A1, an inhibitor of autophagosomal and lyso-
somal fusion (Figures 6F–6I). We also analyzed autophagic flux
using the reporter GFP-mCherry-LC3 (Kimura et al., 2007), which
allows the identification of autolysosomes (mCherry-positive/
GFP-negative; red dots) and autophagosomes (mCherry-posi-
tive/GFP-positive; yellow dots). Our data showed that the totalCellnumbers of autophagosomes and autolysosomes under basal
and amino acid starvation conditions were higher in the
MEKK3- and p38d-deficient cells (Figures 6J and 6K). Taken
together, these results demonstrate that the MEKK3/p38d
cascade modulates autophagy in response to nutrient starva-
tion, consistent with its role in the regulation of mTORC1
activation.
Relevance of the MEKK3/p38d/p62/mTOR Axis in
Prostate Cancer
To investigate the relevance of the p62/MEKK3/p38d cascade in
the activation of mTOR in PCa, we profited from a recently devel-
oped technology for creating 3D prostate organoid cultures (Gao
et al., 2014; Karthaus et al., 2014). Murine prostate organoids
faithfully recapitulate the in vivo phenotypes of genetic PCa
mouse models and can be easily manipulated (Gao et al.,
2014; Karthaus et al., 2014). Thus, we isolated prostate epithelial
cells from PTEN-deficient mice and subjected them to lentiviral
infection to selectively knock down MEKK3, p38d, or p62 and
then cultured them in 3D organoid conditions. Interestingly, we
found that the inactivation of MEKK3, p38d, or p62 decreased
the efficiency of organoid formation and size of organoids and re-
verted the hyperplastic phenotype of the PTEN/ organoids
(Figures 7A and 7B). This strongly suggests an important role
for the MEKK3/p38d cascade in PCa. Notably, the deficiency
in p62, MEKK3, or p38d in these organoids resulted in severe
impairment of S6K and 4EBP1 phosphorylation in this model
(Figure 7C). Consistent with these observations, immunohisto-
chemical analysis of prostates from PTEN+/ mice showed
increased expression of MEKK3, p38d, and p62, as well as the
activation of S6 phosphorylation, which was used as a surrogate
marker of mTORC1 activity, in PIN areas of the prostate, as
compared to normal glands (Figure 7D). Furthermore, we used
double immunofluorescence to analyze the colocalization of
p38d either with p62 or with pS6 in sections of human PCa and
normal prostate tissue. Of great interest, we found that p62
and p38d levels were increased and colocalized with enhancedReports 12, 1339–1352, August 25, 2015 ª2015 The Authors 1347
Figure 6. The MEKK3/p38d Cascade Controlled Cell Proliferation and Autophagy through mTORC1 Activation
(A) MEKK3, p62, or p38d deficiencies reduced cell size. Results are shown as means ± SEM (n = 3). *p < 0.05; **p < 0.01.
(B and C) Knockdown of MEKK3 or p38d reduced cell proliferation under normal growing conditions. shNT, shMEKK3, or shp38d PC3 cells were cultured under
normal growing conditions, and cell viability was determined by trypan blue exclusion assay. Results are shown as means ± SEM (n = 3). *p < 0.05; **p < 0.01.
(D and E) RagBGTP overexpression rescued the defects in cell proliferation inMEKK3- or p38d-knockdown cells. PC3 cells stably expressing FLAG-RagBGTPwere
infected with shNT, shMEKK3, or shp38d lentiviral vectors. Cell lysates were analyzed by western blot, and cell viability was determined as in (C). Results are
shown as means ± SEM (n = 3). *p < 0.05; **p < 0.01.
(legend continued on next page)
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pS6 staining, in tumor tissues as compared to normal controls
(Figure 7E). We next analyzed the expression of MEKK3, p38d,
p62, and phospho-S6 in PCa tissue microarrays by immunohis-
tochemistry. Interestingly, our data showed much stronger
expression of all these proteins in aggressive tumors with high
Gleason score (GS 7–10) than in those with low Gleason score
(GS 2–6; Figure 7F). Importantly, MEKK3 and p38d expression
significantly correlated with p62 and phospho-S6 in these hu-
man PCa samples (Figure 7G). Taken together, these results es-
tablished that the PB1-driven MEKK3/p38d/p62/mTOR pathway
is relevant to PCa.
DISCUSSION
The mechanisms whereby cells couple nutrient availability to
anabolism and cell growth are being progressively unveiled,
and the role of mTORC1 in these processes is well established
(Jewell and Guan, 2013; Laplante and Sabatini, 2012; Shimo-
bayashi and Hall, 2014). A major breakthrough in the field was
the identification of the lysosome as a critical organelle where
mTORC1 is recruited via the Rag proteins and then activated
by as-yet-undefined mechanisms. In addition, how mTORC1
senses the availability of nutrients, and specifically of amino
acids, is a fundamental problem in the field that needs to be
resolved. Here, we show that the signaling adaptor p62, which
we previously demonstrated to contribute to mTORC1 activation
by amino acids (Duran et al., 2011), is phosphorylated at two
specific residues by p38d through a MEKK3/MEK3/6-driven
cascade that enables the recruitment of TRAF6 to the lysosome.
This creates a signaling scaffold with the core mTORC1 complex
that results in the K63 polyubiquitination of mTOR and its activa-
tion in response to amino acids but independent of insulin.
Therefore, p62 emerges as a platform that facilitates the recruit-
ment and efficient activation ofmTORC1. Interestingly, the spec-
ificity of this process is provided by the selective interaction of
MEKK3 with p62 through their respective PB1 domains. In this
regard, although different MAPKs have previously been impli-
cated in the negative or positive control of mTORC1, primarily
in response to stress stimuli (Cully et al., 2010; Li et al., 2003;
Wu et al., 2011; Zheng et al., 2011), our data reveal a specific
role for p38d in mTOR activation in the nutrient cascade as
part of a PB1-directed complex. Our studies contribute to a bet-
ter understanding of the activation of mTORC1 by amino acids,
but also they provide context for previously reported p62 phos-
phorylation events. That is, recent data demonstrate that p62 is
phosphorylated at S351, which serves to increase its binding af-
finity for Keap1 and competitively inhibits the Keap1-Nrf2 inter-
action (Ichimura et al., 2013). This results in the stabilization of
Nrf2 and the subsequent expression of genes encoding antioxi-
dant proteins and anti-inflammatory enzymes (Ichimura et al.,(F–I) Knockdown of MEKK3 or p38d promoted autophagy in response to nutrient d
and serum for 4 hr in the absence or presence of bafilomycin A1. Cell lysates were
as measured by densitometry.
(J and K) Knockdown of MEKK3 or p38d promoted increased autophagic flux. Im
and treated as in (G) are shown. The scale bars represent 10 mm. Quantification of
are shown as means ± SEM (n = 20). *p < 0.05; **p < 0.01; ***p < 0.001.
Results are representative of three experiments.
Cell2013). Interestingly, at least one of the kinases that can target
p62’s S351 is mTOR itself. Therefore, it is tempting to speculate
that the MEKK3-directed phosphorylation of p62 at T269/S272
serves to activate mTORC1, which then phosphorylates p62’s
S351 to activate Nrf2 to protect cells from oxidative stress. In
cancer, this could be highly relevant because tumor cells need
to remove excess ROS while maintaining high levels of prolifer-
ation. Therefore, our model predicts that p62 is a crucial regu-
lator of cancer cell proliferation by influencing cell growth
through mTORC1 and cell survival through an mTORC1-p62-
driven anti-oxidative mechanism.
Interestingly, we have recently reported that MEKK3 is part of
another PB1 complex that activates a canonical MEK4/JNK
cascade to regulate inflammation in macrophages in response
to lipids, another type of nutrients that can trigger an inflamma-
tory response when present in excess (Hernandez et al., 2014).
This distinct MEKK3 pathway is orchestrated by the interaction
of MEKK3 with NBR1 through their respective PB1 domains
(Hernandez et al., 2014). Therefore, two PB1 scaffolds, p62 in
mTORC1 and NBR1 in inflammation, use MEKK3 to deliver
their respective signals in response to different nutrients. How
the interaction of MEKK3 with either p62 or NBR1 orchestrates
the p38d or the JNK pathways, respectively, is not clear and
will likely need more-detailed structural studies to be fully
understood.
In summary, the work presented here describes a nutrient-
sensing pathway that is selectively activated in response to
amino acids and is also operative in cancer cells. This kinase
cascade is organized by a platform that depends on p62 PB1-
domain interactions and is highly upregulated during cancer pro-
gression. Different components of the cascade are overex-
pressed in PCa in a manner that is correlated with tumor stage,
which suggests that the cascade is essential for tumor develop-
ment. Because kinases are eminently druggable targets, our
findings have the potential to open new avenues for designing
novel treatments for cancer.
EXPERIMENTAL PROCEDURES
Mice
PTEN+/ and PTENfl/fl-PBcre mice were described previously (Fernandez-
Marcos et al., 2009). Both mouse strains were generated in a C57BL/6 back-
ground. All mice were born and maintained under pathogen-free conditions.
Animal handling and experimental procedures conformed to institutional
guidelines (Sanford-Burnham Medical Research Institute Institutional Animal
Care and Use Committee).
Generation of Knockout Cell Lines
To knock out genes in cell lines, guide RNAs targeting MEKK3, p38d, and p62
were designed using the CRISPR design tool at http://crispr.mit.edu/ and
cloned into a bicistronic expression vector (PX458) containing human-
codon-optimized Cas9 fused to EGFP through T2A sequence and the RNAeprivation. shNT, shMEKK3, or shp38d PC3 cells were deprived of amino acids
immunoblotted for the indicated proteins. Graphs represent LC3-II/actin ratio
ages of shNT, shMEKK3, or shp38d cells stably expressing GFP-mCherry-LC3
the number of autophagosomes and autolysosomes per cell is shown. Results
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Figure 7. MEKK3/p38d/p62/mTOR Is Relevant to Prostate Cancer
(A) Knockdown of MEKK3, p38d, or p62 led to a reduction in the efficiency of organoid formation, size, and hyperplastic phenotype of PTEN-null prostate or-
ganoids. Representative images of organoids and H&E staining are shown. Prostate organoids were prepared from PTENfl/fl-PBcre mice and infected with
lentiviral vectors for shNT, shp62, shMEKK3, and shp38d. Organoids were analyzed after 7 days in culture. The scale bars represent 100 mm.
(legend continued on next page)
1350 Cell Reports 12, 1339–1352, August 25, 2015 ª2015 The Authors
components (Addgene). Additional detailed procedures are described in the
Supplemental Experimental Procedures.
Statistical Analysis
All the statistical tests are justified for every figure. Data are presented as the
mean ±SEM. Significant differences between groups were determined using a
Student’s t test (two-tailed unpaired) when the datamet the normal distribution
tested by D’Agostino test. If the data did not meet this test, a Mann-Whitney
test was used. The significance level for statistical testing was set at p <
0.05. All experiments were performed at least two or three times.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.07.045.
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